Filing Details
- Accession Number:
- 0000950170-23-048794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-19 16:30:08
- Reporting Period:
- 2023-09-15
- Accepted Time:
- 2023-09-19 16:30:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1861113 | Daniel Niedzwiecki | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-15 | 2,846 | $17.79 | 69,141 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-09-15 | 2,846 | $66.43 | 66,295 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2023-09-15 | 2,846 | $0.00 | 2,846 | $17.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-11-06 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
- The stock options under this grant vested in equal installments over a four-year period beginning on November 6, 2013.